Significant stock movers of September: Viking soars, Longeveron slides

Data ReadoutpositivePositive

AI Analysis

Summary

Viking Therapeutics announced strong obesity data and completed a major capital raise, driving stock gains, while Longeveron experienced a mid-stage trial setback that prompted concerns about its future trajectory.

Outcome Details

Strong obesity data

Importance:5/10

Sentiment:

0.30

obesityclinical datacapital raisestock movementmid-stage setback

Related Companies

$VKTX $LGVN

Read the original article

Published by BioSpace on October 5, 2026 6:24 PM

Read Original